From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies

The in-depth, constantly-changing birds-eye view of disease that computational models provide is an essential next step in linking our ever-expanding clinical knowledge and data with drug development. The post From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies appeared first on MedCity News.

Read More

Cadence Rakes In $100M to Automate Chronic Care at Scale

Cadence raised $100 million in Series C funding to scale its AI-powered chronic care platform, which monitors patients at home and adjusts their medications in real time.The startup, now valued at $1.23 billion, partners with health systems to treat patients with heart failure, hypertension and diabetes. The post Cadence Rakes In $100M to Automate Chronic…

Read More

Startup Raises $7M for Virtual-First Pediatric Therapy Model

Ladder Health’s seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures. The post Startup Raises $7M for Virtual-First Pediatric Therapy Model appeared first on MedCity News.

Read More